Changes in Insulin Resistance in Healthy Volunteers on STRIBILD® Medication - A Controlled, Mono Center, Three-arm, Randomized Phase I Study.
Phase of Trial: Phase I
Latest Information Update: 07 Nov 2014
Price : $35 *
At a glance
- Drugs Elvitegravir/emtricitabine/tenofovir disoproxil fumarate/cobicistat (Primary) ; Darunavir; Emtricitabine/tenofovir disoproxil fumarate; Lopinavir/ritonavir; Ritonavir
- Indications HIV infections
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 04 Nov 2014 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
- 06 Aug 2014 New trial record